AlfthanO., JauhianenK., KangasL., KepylaM.: Superficial urinary bladder carcinoma: chemotherapy, immunotherapy, retinoids and prevention of relapses. Intern. J. Immunother., 11; 5–17 (1986).
2.
BarnesR., HadleyH., DickA., JohnstonO., DexterJ.: Changes in grade and stage of recurrent bladder tumors. J. Urol., 118; 177 (1977).
3.
GreenD. F., RobinsonM. R. G., GlashanR., NewlingD., DalesioO., SmithP. H.: Does intravesical chemotherapy prevent invasive bladder cancer?. J. Urol., 131; 33–35 (1984).
4.
HulandJ., OttoU., DroeseM., KloppelG.: Long-term Mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J. Urol., 132; 27–29 (1984).
5.
JauhianenK., AlfthanO.: Instillation of Mitomycin C and Doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer. Brit. J. Urol., 60; 54–59 (1987).
6.
NijimaT., KoisoK., AzokaH.(Japanese Urological Cancer Research Group for adriamycin): Randomized clinical trial on chemoprophylaxis of recurrence in case of superficial bladder cancer. Cancer Chemother. Pharmacol., 11; (Suppl.) 579 (1983).
7.
PocockR. D., PonnerB. A., O'SullivanJ. P., IbrahimS. K., EastonD. F., ShearerR. J.: Prognostic factors in non infiltrating carcinoma of the bladder: a preliminary report. Brit. J. Urol., 54; 711 (1982).
8.
SchulzW., LeyhH., KuntzR. M.: Topical instillation of Mitomycin C in the treatment of superficial bladder tumor. J. Urol., 131; part 2, 140A (1984).
9.
SolowayM. S.: The management of superficial bladder cancer. Cancer, 45; 1856 (1980).
